Contract

Varicose Vein Treatment

  • Milton Keynes University Hospital NHS Foundation Trust

F03: Contract award notice

Notice identifier: 2024/S 000-035390

Procurement identifier (OCID): ocds-h6vhtk-04b317

Published 31 October 2024, 4:48pm



Section one: Contracting authority

one.1) Name and addresses

Milton Keynes University Hospital NHS Foundation Trust

Standing Way, Eaglestone

Milton Keynes

MK6 5LD

Contact

Lisa Johnston

Email

lisa.johnston@mkuh.nhs.uk

Country

United Kingdom

Region code

UKJ12 - Milton Keynes

Internet address(es)

Main address

https://www.mkuh.nhs.uk/

Buyer's address

https://www.mkuh.nhs.uk/

one.4) Type of the contracting authority

Regional or local authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Varicose Vein Treatment

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

The Vascular service currently doesn't have a treatment option for varicose vein patients. The vein centre offers this treatment to our patients who are currently sitting on our PTL. Prior to having this option our patients would remain on the PTL and became long waiters. There is a plan for thr future once the Trust offers radiofrequency ablation in the Treatment room.

This outsourcing solution should align to the following:
• Have the ability to align capacity with the defined volumes to acheive the clearance rate required
• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £316,548

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKJ12 - Milton Keynes
Main site or place of performance

Milton Keynes

two.2.4) Description of the procurement

Services:
The Vascular service currently doesn't currently have a treatment option for varicose vein patients. The vein centre offers this treatment to patients who are currently sitting on our PTL. Prior to having this option our patients would remain on the PTL and became long waiters.
This outsourcing solution should align to the following:
• Have the ability to align capacity with the defined volumes to acheive the clearance rate required
• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes

The Authority intends to award a contract to an existing provider following direct award process C

The approximate lifetime value of the contract is £316,548.00

The services are intended to be provided from 01/10/2024 - 31/03/2025

The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.

two.2.5) Award criteria

Quality criterion - Name: the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard / Weighting: 100

Price - Weighting: 100

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • The procurement falls outside the scope of application of the regulations

Explanation:

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 12/11/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

1 October 2024

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Veincentre Limited

Unit 5 Lyme Drive Stoke-on- Trent

Stoke-on-Trent

ST4 6NW

Country

United Kingdom

NUTS code
  • UKG23 - Stoke-on-Trent
The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £316,548

Total value of the contract/lot: £316,548


Section six. Complementary information

six.3) Additional information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 12/11/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Written representations can be sent to: Lisa.Johnston@mkuh.nhs.uk

Award decision makers:
Jonathan Dunk – Chief Finance Officer
Fay Gordon – Chief Operating Officer
Claire McGillycuddy - ADO Surgery and Planned Care General Surgery
Arosha Hettiarachchige - Operational Manager General Surgery

Conflicts of interest identified: none.

Key Criteria 1: Quality and Innovation

The Vascular service currently doesn't have a treatment option for varicose vein patients. The vein centre offers this treatment to our patients who are currently sitting on our PTL. Prior to having this option our patients would remain on the PTL and became long waiters. There is a plan to move away from the Vein Centre once we offer radiofrequency ablation in the Treatment room.

This outsourcing solution should align to the following:
• Have the ability to align capacity with the defined volumes to acheive the clearance rate required
• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes

The current insourcing provider is successfully delivering against the ciriteria.

• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.
• The insourcing provider will configure service delivery within confines of the contract.

Key criteria 2: Value
The value of the contract is £316,548 over a period of 6 months, and should deliver the following non-finanical benefits:
• Reduction in backlogs
• Increase access to timely care and treatment
• Improved patient experience

The current insourcing provider is successfully delivering against the criteria.

• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.
• The insourcing provider will configure service delivery within confines of the contract.


Key criteria 3: Integration, collaboration and service sustainability

Since the Vascular service is unable to currently offer varicose vein patients with treatment, not having the Vein Centre would lead to an increase in our long waiters. This will result in compromising patient safety, care and experience. Keeping the outsourcing service would ensure that we continue to tackle backlog of longest waiting patients for varicose vein treatment.

This outsourcing solution should align to the following:
• Have the ability to align capacity with the defined volumes to achieve the clearance rate required
• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes.

The current insourcing provider is successfully delivering against the criteria.

• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.
• The insourcing provider will configure service delivery within confines of the contract.

Key criteria 4: Improving access, reducing health inequalities and facilitating choice

Since the Vascular service is unable to currently offer varicose vein patients with treatment, not having the Vein Centre would lead to an increase in our long waiters. This will result in compromising patient safety, care and experience. Keeping the outsourcing service would ensure that we continue to tackle backlog of longest waiting patients for varicose vein treatment.

This outsourcing solution should align to the following:
• Have the ability to align capacity with the defined volumes to achieve the clearance rate required.
• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes

The current insourcing provider is successfully delivering against the criteria.

• Given capacity constraints areound varicose vein treament volumes within the contract have been increased.
• The insourcing provider will configure service delivery within confines of the contract.

Key Criteria 5: Social Value
Given that the treatment is currently not offered at MKUH the outsourcing provider will deliver the following benefits in relation to social value:

• Reduced human suffering
• Increase access to varicose vein care/ treatment.

The current insourcing provider is successfully delivering against the criteria.

• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.
• The insourcing provider will configure service delivery within confines of the contract.

Basic selection criteria:
The provider was selected based on the weighting of the following criteria:
• Experience in delivering pathways aligned to the the treatment of varicose veins
• Have the ability to align capacity with the defined volumes to acheive the clearance rate required
• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes

six.4) Procedures for review

six.4.1) Review body

NHS Bedfordshire, Luton and Milton Keynes Integrated Care Board

3rd Floor, Arndale House, The Mall

Luton

LU1 2LJ

Country

United Kingdom

Internet address

https://www.bedfordshirelutonandmiltonkeynes.icb.nhs.uk/